The levels of neuronal COX-2 expression observed in post mortem brain tissue correlate well with recent clinical data presented by Combrinck and colleagues [21] describing, compared to control patients, higher prostaglandin E2 levels in the cerebrospinal fluid in patients with mild memory impairment, but lower in those with more advanced AD. The gene discussed is PTGS2; the disease is Alzheimer disease.